| 名稱 | CYP2D6*2 Reference Standard |
| 型號 | CBPA0045 |
| 報價 |  |
| 特點 | CYP2D6*2 Reference Standard |
產品搜索
相關文章
聯系我們
產品展示 / PRODUCTS
- 詳細內容
| CBPA0045 | |
| Format | Genomic DNA |
| Description | CYP2D6, cytochrome P450 family 2 subfamily D member 6, is a member of the cytochrome P450 family of monooxygenases that catalyzes drug metabolism (PMID: 28480783). CYP2D6 variants have been associated with risks of various cancers (PMID: 22994728, PMID: 16550168) and may alter the metabolism of tamoxifen in breast cancer patients. |
| Technical Data | |
| Gene | CYP2D6*2 |
| Mutation Type 1 | AA Change: p.R296C |
| DNA Change: NM_000106.6:c.886C>T | |
| Chr position (GRCh38): NC_000022.11:g.42127941G>A | |
| Mutation Type 2 | AA Change: p.S486T |
| DNA Change: NM_000106.6:c.1457G>C | |
| Chr position (GRCh38):NC_000022.11:g.42126611C>G | |
| Allelic Frequency | 50% |
| Zygosity | Heterozygous |
| Product Information | |
| Intended Use | Research Use Only |
| Unit Size | 1ug |
| Concentration | Download for COA |
| Purofication | Download for COA |
| DNA electrophoresis | Download for COA |
| Sanger sequencing |
Figure 1. CYP2D6*2 Reference Standard p.R296C
Figure 2. CYP2D6*2 Reference Standard p.S486T |
| Storage | 4°C |
| Expiry | 36 months from the date of manufacture |
